Advertisement #1
Home Clinical development Phase I

Phase I

Phase I

Sonodynamic Therapy: An Emerging Treatment for Deadly Brain Tumors

Ely Benaim, MD -

Positive Interim Phase 2 Results for BOLD-100 in Advanced Gastric and Biliary Tract Cancer

Editorial Team -

What to Expect at ASCO ’23: A Trial In Progress Update of Mythic Therapeutics’...

Editorial Team -

Sudocetaxel Zendusortide Shows Potential as a Single Agent and as a Combination Therapy

Editorial Team -

Study Shows Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104

Editorial Team -

How Whole Exome Sequencing Improves Identification of People With Cancer Predisposition Syndromes

Editorial Team -

REGN5459 Shows Encouraging Clinical Activity in Patients With r/r Multiple Myeloma

Editorial Team -

Preclinical Characterization of Anti-SIRPα mAb BYON4228 Shows Encouraging and Favorable Profile

Editorial Team -

First Patient Dosed in Phase 1/1b Dose Escalation/Expansion Study of PRGN-3007 in Advanced ROR1+

Editorial Team -

Researchers Identify Potential Targets to Overcome Treatment Resistance in Aggressive Breast Cancer

Editorial Team -
123...6Page 1 of 6

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X